6XS Stock Overview
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Cel AI PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.0045 |
52 Week High | UK£0.015 |
52 Week Low | UK£0.001 |
Beta | -1.5 |
1 Month Change | 0% |
3 Month Change | 50.00% |
1 Year Change | n/a |
3 Year Change | -95.00% |
5 Year Change | n/a |
Change since IPO | -97.17% |
Recent News & Updates
Recent updates
Shareholder Returns
6XS | DE Personal Products | DE Market | |
---|---|---|---|
7D | 0% | 1.9% | -1.2% |
1Y | n/a | -0.5% | 1.8% |
Return vs Industry: Insufficient data to determine how 6XS performed against the German Personal Products industry.
Return vs Market: Insufficient data to determine how 6XS performed against the German Market.
Price Volatility
6XS volatility | |
---|---|
6XS Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 4.7% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6XS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 6XS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | 5 | n/a | www.getcel.ai |
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.
Cel AI PLC Fundamentals Summary
6XS fundamental statistics | |
---|---|
Market cap | €1.58m |
Earnings (TTM) | -€3.87m |
Revenue (TTM) | €78.61k |
20.2x
P/S Ratio-0.4x
P/E RatioIs 6XS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6XS income statement (TTM) | |
---|---|
Revenue | UK£67.24k |
Cost of Revenue | UK£25.80k |
Gross Profit | UK£41.44k |
Other Expenses | UK£3.35m |
Earnings | -UK£3.31m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0055 |
Gross Margin | 61.63% |
Net Profit Margin | -4,922.54% |
Debt/Equity Ratio | 0% |
How did 6XS perform over the long term?
See historical performance and comparison